Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prieto, V. G.
Right arrow Articles by Bar-Eli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prieto, V. G.
Right arrow Articles by Bar-Eli, M.
Clinical Cancer Research Vol. 12, 6709-6715, November 15, 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

Victor G. Prieto1,2, Alexandra A. Mourad-Zeidan3, Vladislava Melnikova3, Marcella M. Johnson4, Adriana Lopez4, A. Hafeez Diwan1,2, Alexander J.F. Lazar1,2, Steven S. Shen6, Peter S. Zhang1, Jon A. Reed7, Jeffrey E. Gershenwald3,5, Avraham Raz8 and Menashe Bar-Eli3

Authors' Affiliations: Departments of 1 Pathology, 2 Dermatology, 3 Cancer Biology, 4 Biostatistics, and 5 Surgical Oncology, The University of Texas M.D. Anderson Cancer Center; 6 Department of Pathology, The Methodist Hospital; 7 Departments of Pathology and Dermatology, Baylor College of Medicine, Houston, Texas; and 8 Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

Requests for reprints: Victor G. Prieto, Department of Pathology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-3187; Fax: 713-745-3740; E-mail: vprieto{at}mdanderson.org.

Purpose: Most studies accept a multistep pathogenic process in melanoma that may include the phases of benign nevi and dysplastic nevi, melanoma, and metastatic melanoma. Dysregulation of cellular proliferation and apoptosis is probably involved in melanoma progression and response to therapy. We have studied the expression of galectin-3, a ß-galactoside-binding protein involved in apoptosis, angiogenesis, and cell proliferation, in a large series of melanocytic lesions, and correlated the expression with clinical and histologic features.

Experimental Design: Tissue microarray blocks of 94 melanocytic lesions were semiquantitatively evaluated by immunohistochemistry for the cytoplasmic or nuclear expression of galectin-3.

Results: Primary and metastatic melanomas expressed galectin-3 at a significantly higher level than nevi in both cytoplasm and nuclei (P < 0.0073). There was a significant association between anatomic source (as indirect indication of level of sun-exposure) and cytoplasmic and nuclear expression. Lymph node and visceral metastases had a higher level of expression than s.c. lesions (P < 0.004). Interestingly, there was an almost significant finding of worse survival in those patients with lesions showing higher levels of cytoplasmic than nuclear galectin-3 expression (log-rank test, P = 0.06).

Conclusions: Melanocytes accumulate galectin-3 with tumor progression, particularly in the nucleus. The strong association of cytoplasmic and nuclear expression in lesions of sun-exposed areas suggests an involvement of UV light in activation of galectin-3.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. Chakravarti, R. Lotan, A. H. Diwan, C. L. Warneke, M. M. Johnson, and V. G. Prieto
Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis
Clin. Cancer Res., August 15, 2007; 13(16): 4817 - 4824.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.